Key facts
- Aerin Medical’s last known valuation is $349.5M (Dec 2024).
- It has raised $258.0M across 7 recorded rounds; the latest was Early Stage VC ($32.5M) in Dec 2024.
- Notable investors include OrbiMed, Ally Bridge Group, Ares Management, KCK Group, Barshop Ventures — 16 tracked in total.
- Aerin Medical has filed 11 Form Ds with the SEC since 2011, most recently Dec 2024 ($32.5M sold to 23 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 7 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Aerin Medical
Funding rounds
7 roundsAbout Aerin Medical
Developer of non-invasive medical devices designed to provide relief for chronic nasal conditions. The company offers a compact touch-screen console that utilizes temperature-controlled radiofrequency technology to deliver precise treatments for nasal airway obstruction and chronic rhinitis, enabling physicians to effectively manage these conditions for patients seeking lasting relief.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2011
- Employees
- 155
- Website
- aerinmedical.com/
- Ownership
- Privately Held (backing)
Aerin Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aerin Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aerin Medical in its N-PORT filings yet. We sweep new filings monthly.